Diagnosis of Bladder Cancer

Abstract

Transitional-cell carcinoma, which constitutes the vast majority of bladder cancers in the United States, may develop as carcinoma in situ or as invasive carcinoma. This article focuses on transitional-cell carcinoma with a review of the major aspects of the disease, including the epidemiology, diagnosis and staging, and management. Therapeutic options are explored, including surgery, radiotherapy, chemotherapy, and combined modality therapy.